|
|
||||||||
61 Dept of Respiratory Medicine, The London Chest Hospital, 2 Lung Pathology, Imperial College London at the Royal Brompton Hospital, and 4 Dept of Respiratory Medicine, Newham University Hospital NHS Trust, London, and 9 Dept of Respiratory Medicine, Glenfield Hospital, Leicester, UK. 3 Dept of Pulmonology, Leiden University Medical Centre, Leiden, The Netherlands. 5 Massey University School of Health Sciences, Auckland, New Zealand. 6 Institute of Respiratory Pathophysiology, Palermo, Italy. 7 Dept of Pneumology and Allergy, University Medical Clinic, Jena, Germany. 8 Pneumology Service, Tres Torres Clinic, Vall dHebron Hospital, Barcelona, Spain.
CORRESPONDENCE: N. C. Barnes, Dept of Respiratory Medicine, London Chest Hospital, Bonner Road, London, E2 9JX, UK. Fax: 44 2089832279. E-mail: neil.barnes{at}bartsandthelondon.nhs.uk
Keywords: Chronic obstructive pulmonary disease, inflammation, smoking, smoking cessation
Received: January 27, 2006
Accepted May 7, 2007
Bronchial biopsy specimens from chronic obstructive pulmonary disease (COPD) patients demonstrate increased numbers of CD8+ T-lymphocytes, macrophages and, in some studies, neutrophils and eosinophils. Smoking cessation affects the rate of forced expiratory volume in one second (FEV1) decline in COPD, but the effect on inflammation is uncertain. Bronchial biopsy inflammatory cell counts were compared in current and ex-smokers with COPD.
A pooled analysis of subepithelial inflammatory cell count data from three bronchial biopsy studies that included COPD patients who were either current or ex-smokers was performed.
Cell count data from 101 subjects, 65 current smokers and 36 ex-smokers, were analysed for the following cell types: CD4+ and CD8+ T-lymphocytes, CD68+ (monocytes/macrophages), neutrophil elastase+ (neutrophils), EG2+ (eosinophils), mast cell tryptase+ and cells mRNA-positive for tumour necrosis factor-
It is concluded that, in established chronic obstructive pulmonary disease, the bronchial mucosal inflammatory cell infiltrate is similar in ex-smokers and those that continue to smoke.
. Current smokers and ex-smokers were similar in terms of lung function, as measured by FEV1 (% predicted), forced vital capacity (FVC) and FEV1/FVC. The results demonstrate that there were no significant differences between smokers and ex-smokers in the numbers of any of the inflammatory cell types or markers analysed.
This article has been cited by other articles:
![]() |
M. Tsoumakidou, I. K. Demedts, G. G. Brusselle, and P. K. Jeffery Dendritic Cells in Chronic Obstructive Pulmonary Disease: New Players in an Old Game Am. J. Respir. Crit. Care Med., June 1, 2008; 177(11): 1180 - 1186. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. MacNee Update in Chronic Obstructive Pulmonary Disease 2007 Am. J. Respir. Crit. Care Med., April 15, 2008; 177(8): 820 - 829. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |